Will a drug that didn't go through human clinical trials be approved by 2034?
One-OffRegulierungHealth & Medicine8JManifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseNein 72.4%
Prognostiker
24
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 14 Stunden
Veraltet14. Apr. 24, 19:22 UTC1. Jan. 35, 22:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Tdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
FutuurHow many clinical trials will have started in Prospera by Dec 31, 2026?
FutuurWill China have more phase 3 drug trials than the United States in year X?
Manifold MarketsWill Retatrutide (new obesity drug) be FDA approved by the end of 2026?
Manifold MarketsThe Netflix/Warner deal will go through
Manifold MarketsRaniPill microneedle pill to replace injections: approved for sale by the end of 2026?
FutuurRegeln
Drug development currently involves the use of AI to search for new compounds but still relies on various phases of testing on human trials to ensure efficacy and safety.
- An option to skip human testing would be to rely on accurate simulations of the human body, but this would require advanced models that can accurately represent the complex interactions within human biology, including genetic variations and long-term effects.
- Achieving this requires vast computational power, sophisticated algorithms, a deeper integration of diverse biological data and obviously overcoming regulations.
- As far as I understand, the computational requirements for such an effort would be in the realm of exaflops, not far from current supercomputers.
- What are the odds to have an AI generated drug that skips human testing within a decade?
- Feel free to comment and share your thoughts and insights!
Offene Märkte
Regulation
POLYMARKETClarity Act (H.R.3633) signed into law in 2026?
- No+2.0pt86%
- Yes-2.0pt14%
- Gesamtvolumen
- 12,4 Mio. €
- 24h-Volumen
- 182.343,6 €
POLYMARKETAnthropic IPO by which date?
- December 31,-1.0pt90%
- December 15,+3.5pt90%
- November 30,85%
+7 weitere Ergebnisse
- Gesamtvolumen
KALSHIWill the Clarity Act become law?
- Before Jan 1, 2028-14.0pt40%
- Before Jul 1, 2027-5.0pt37%
- Before Oct 1, 2027-16.0pt33%
+7 weitere Ergebnisse
KALSHIWhen will Tesla and SpaceX merge?
- Before 2028+3.0pt67%
- Before May 1, 2027-1.0pt49%
- Before Apr 1, 2027-7.0pt43%
+8 weitere Ergebnisse
KALSHIWhen will Anthropic officially announce an IPO?
- Before Apr 1, 2027+5.0pt97%
- Before Jan 1, 202795%
- Before Mar 1, 2027-1.0pt94%
+9 weitere Ergebnisse
- Gesamtvolumen
- 1,4 Mio. €
POLYMARKETWhat will OpenAI's IPO valuation be?
- $1.25T–$1.5T-0.1pt20.4%
- $1.75T–$2.0T19.4%
- $1.5T–$1.75T+0.1pt18.4%
+5 weitere Ergebnisse
- Conference to Win the National Championship
- Will California authorize an alternative wage or other qualifying relief from goat-herder wage and overtime obligations before Oct 1, 2026?
- Which companies will officially announce an IPO this year?
- Discord IPO Closing Market Cap
- When will the Senate vote on the Clarity Act?
- SpaceX' Market Cap end of October 2026?
- Which Senators will vote for the Clarity Act?
- Space Exploration Technologies' Market Cap end of September 2026?
- Will Delaware raise its corporate franchise tax?
- Will marijuana be rescheduled?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will a drug that didn't go through human clinical trials be approved by 2034??
- Manifold Markets bewertet No mit 72% (Stand: 8. September 2026).
- Wann wird Will a drug that didn't go through human clinical trials be approved by 2034? entschieden?
- Will a drug that didn't go through human clinical trials be approved by 2034? soll am 1. Januar 2035 entschieden werden.
- Wie wird Will a drug that didn't go through human clinical trials be approved by 2034? abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: Drug development currently involves the use of AI to search for new compounds but still relies on various phases of testing on human trials to ensure efficacy and safety.